EBV-positive mucocutaneous ulcer

Clinical trials for EBV-positive mucocutaneous ulcer explained in plain language.

Never miss a new study

Get alerted when new EBV-positive mucocutaneous ulcer trials appear

Sign up with your email to follow new studies for EBV-positive mucocutaneous ulcer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Immunotherapy duo takes on tough lymphomas

Disease control Ongoing

This phase 2 trial tests whether adding varlilumab to nivolumab helps people with aggressive B-cell lymphomas that have returned or not responded to treatment. About 54 participants will receive either nivolumab alone or nivolumab plus varlilumab. The goal is to see if the combin…

Matched conditions: EBV-POSITIVE MUCOCUTANEOUS ULCER

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

EBV-positive mucocutaneous ulcer

Get alerted when new EBV-positive mucocutaneous ulcer trials appear

Immunotherapy duo takes on tough lymphomas